You are here

Healthcare Economics

 

Harvard Pilgrim Health Care signed an outcomes-based refund contract with Amgen pertaining to evolocumab (Repatha), the company’s cholesterol-lowering medication.

An analysis of Open Payments reports found that 74.9 percent of cardiologists in the U.S. received industry-related payments in 2015, representing the highest proportion within physician specialties.

Adults who had favorable cardiovascular health in early middle age lived an average of 3.9 years longer, survived 4.5 years longer before developing a chronic illness and saved nearly $18,000 in Medicare costs compared with those with two or more risk factors at middle age, according to a longitudinal cohort study.

The Partners HealthCare System and Brigham and Women’s Hospital agreed to pay $10 million to resolve allegations that the hospital’s stem cell research laboratory fraudulently obtained grant funding.

A jury in Los Angeles this week awarded former Cardiovascular Systems sales manager Steven Babyak more than $25 million in damages related to a whistleblower and wrongful termination lawsuit he filed against the company.

 

Recent Headlines

AHA awards $2 million to cardiac research at top universities

The American Heart Association (AHA) announced May 19 that it will donate two $1 million research grants to support research on medications and high blood pressure.

ACC president emphasizes access to insurance, quality care in letter to Senate

The repeal-and-replace program for the Affordable Care Act (ACA) has passed through the U.S. House of Representatives, meaning the Senate will soon begin work on comprehensive legislation. Debate remains just how much the Senate will take from the House’s American Health Care Act.

Amgen, Harvard Pilgrim sign outcomes-based refund contract for cardiovascular medication

Harvard Pilgrim Health Care signed an outcomes-based refund contract with Amgen pertaining to evolocumab (Repatha), the company’s cholesterol-lowering medication.

75% of cardiologists receive industry-related payments

An analysis of Open Payments reports found that 74.9 percent of cardiologists in the U.S. received industry-related payments in 2015, representing the highest proportion within physician specialties.

Favorable middle-age cardiovascular health reduces costs, improves long-term outcomes

Adults who had favorable cardiovascular health in early middle age lived an average of 3.9 years longer, survived 4.5 years longer before developing a chronic illness and saved nearly $18,000 in Medicare costs compared with those with two or more risk factors at middle age, according to a longitudinal cohort study.

Boston Scientific posts revenue, earnings growth in 1Q

During the first quarter of 2017, Boston Scientific’s sales increased 10 percent to $2.16 billion compared with the same time period last year. The company also reported GAAP earnings of $0.21 per share, up from $0.15 per share in the first quarter of 2016.

Partners HealthCare System settles for $10 million to resolve fraud allegations

The Partners HealthCare System and Brigham and Women’s Hospital agreed to pay $10 million to resolve allegations that the hospital’s stem cell research laboratory fraudulently obtained grant funding.

CardioNet agrees to $2.5 million fine, corrective action plan to settle HIPAA allegations

CardioNet agreed to pay $2.5 million and implement a corrective action plan to settle allegations of noncompliance with HIPAA privacy and security rules.

Jury awards ex-Cardiovascular Systems employee $25.1 million in whistleblower lawsuit

A jury in Los Angeles this week awarded former Cardiovascular Systems sales manager Steven Babyak more than $25 million in damages related to a whistleblower and wrongful termination lawsuit he filed against the company.

MyoKardia appoints physician, executive David Meeker to board of directors

MyoKardia named pharmaceutical executive and physician David Meeker, MD, to its board of directors on April 18.

Pages